Recombinant gp160 as a therapeutic vaccine for HIV-infection: results of a large randomized, controlled trial. European Multinational IMMUNO AIDS Vaccine Study Group.

FD Goebel, W. Engl, Vesna Blazevic, JW Mannhalter, RB Belshe, MM Eibl, PJ Grob, V de Gruttola, PD Griffiths, V Erfle, M Kunschak

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
Publication statusPublished - 1999
Externally publishedYes
Publication typeA1 Journal article-refereed

Cite this